Реестр международных мультицентровых клинических исследований лекарств в Украине

Study List:

Studie 1:
Titel: Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Thyroid Cancer|Thyroid Disease
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00341094

Studie 2:
Titel: Methadone Maintenance & HIV Risk in Ukraine
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Opioid Dependence
Interventions: Arzneimittel: Methadone
URL: http://ClinicalTrials.gov/show/NCT00351026

Studie 3:
Titel: Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine
Recruitment: Not yet recruiting
Study Results: No Results Available
Conditions: HIV Infections|Intervention
Interventions: Behavioral: Peer Education Model|Behavioral: HIV Counseling and Education Model
URL: http://ClinicalTrials.gov/show/NCT01159704

Studie 4:
Titel: Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
Recruitment: Completed
Study Results: No Results Available
Conditions: Leukämie
Interventions: Behavioral: Occupational Radiation Safety Standards
URL: http://ClinicalTrials.gov/show/NCT00341016

Studie 5:
Titel: Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
Recruitment: Completed
Study Results: Has Results
Conditions: Respiratory Tract Infections
Interventions: Arzneimittel: Clarithromycin (Klacid SR)
URL: http://ClinicalTrials.gov/show/NCT01095978

Studie 6:
Titel: Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Studyy
Recruitment: Completed
Study Results: No Results Available
Conditions: Thyroid Cancer
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01265381

Studie 7:
Titel: Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
Recruitment: Completed
Study Results: No Results Available
Conditions: Advanced Prostate Cancer|Lower Urinary Tract Symptoms
Interventions: Arzneimittel: Leuprolide acetate Depot Susp. 11,25 mg (Polen), 3,75 mg (Ukraine)
URL: http://ClinicalTrials.gov/show/NCT01078545

Studie 8:
Titel: International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Environment
Interventions:
URL: http://ClinicalTrials.gov/show/NCT00339274

Studie 9:
Titel: Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice
Recruitment: Recruiting
Study Results: No Results Available
Conditions: General Surgery
Interventions: Arzneimittel: sevoflurane
URL: http://ClinicalTrials.gov/show/NCT01282086

Studie 10:
Titel: Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV
Recruitment: Enrolling by invitation
Study Results: No Results Available
Conditions: TB|HIV
Interventions: Dietary Supplement: Immunoxel|Arzneimittel: Placebo|Arzneimittel: TB drugs+ Immunoxel|Arzneimittel: ATT+Placebo|Arzneimittel: ATT + Placebo|Arzneimittel: arzneimittelresistente Tuberkulose unter ATT+Immunoxel|Arzneimittel: Immunoxel
URL: http://ClinicalTrials.gov/show/NCT01061593

Studie 11:
Titel: Phase-II-Studie zum Vergleich von ABI-007 zu Taxotere in der Erstlinientherapie von Patientinnen mit Brustkrebs im Stadium IV
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Metastasierter Brustkrebs
Interventions: Arzneimittel: Araxane vs. Thaxotree
URL: http://ClinicalTrials.gov/show/NCT00274456

Studie 12:
Titel: Wirksamkeit und Verträglichkeit von Beclomethason plus Salbutamol in der HFA-pMDI-Fixkombination im Vergleich zu Beclomethason plus Salbutamol in der CFC-pMDI-Fixkombination in einem 12-wöchigen Behandlungszeitraum erwachsener Patienten mit unkontrolliertem Asthma
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma bronchiale
Interventions: Arzneimittel: Salbutamol 100 mcg|Arzneimittel: BDP/Salbutamol HFA pMDI|Arzneimittel: BDP/Salbutamol FCKW pMDI
URL: http://ClinicalTrials.gov/show/NCT00528723

Studie 13:
Titel: Studie zur Bewertung der Sicherheit und Wirksamkeit einer einmal täglichen Dosis Tigecyclin im Vergleich zu Ertapenem bei diabetischen Fußinfektionen (DFI) Mit einer Teilstudie bei Patienten mit durch Osteomyelitis komplizierten diabetischen Fußinfektionen.
Recruitment: Completed
Study Results: Has Results
Conditions: Bakterielle Infektionen|Diabetischer Fuß|Osteomyelitis
Interventions: Arzneimittel: Tigecyclin|Arzneimittel: Ertapenem
URL: http://ClinicalTrials.gov/show/NCT00366249

Studie 14:
Titel: Studie zur Bewertung von PPM-204 bei Probanden mit Typ 2 Diabetes
Recruitment: Beendet
Study Results: No Results Available
Conditions: Diabetes mellitus
Interventions: Arzneimittel: PPM-204
URL: http://ClinicalTrials.gov/show/NCT00425919

Studie 15:
Titel: Studie zur Bewertung von DVS-233 SR zur Behandlung vasomotorischer Symptome im Zusammenhang mit der Menopause
Recruitment: Completed
Study Results: No Results Available
Conditions: Menopause
Interventions: Arzneimittel: DVS-233
URL: http://ClinicalTrials.gov/show/NCT00195546

Studie 16:
Titel: Tuberkulose (TB) Immuntherapiephase 2 Studie
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Tuberkulose
Interventions: Biologisch: V7|Andere: Placebo
URL: http://ClinicalTrials.gov/show/NCT01380119

Studie 17:
Titel: HIV-Präventionsprozess gegen russische Arbeitsmigranten
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: HIV
Interventions: Behavioral: Intervention in sozialen Netzwerken
URL: http://ClinicalTrials.gov/show/NCT01177995

Studie 18:
Titel: Prozess gegen FOLF(HA)Iri versus FOLFIRI bei mCRC
Recruitment: Not yet recruiting
Study Results: No Results Available
Conditions: Metastasierter Darmkrebs
Interventions: Arzneimittel: Irintoecan|Arzneimittel: HA-Irinotecan-Infusionslösung
URL: http://ClinicalTrials.gov/show/NCT01290783

Studie 19:
Titel: Phase-III-Studie mit Teriflunomid im Vergleich zu Placebo bei Patienten mit ersten klinischen Symptomen von Multipler Sklerose
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Multiple Sklerose
Interventions: Arzneimittel: Teriflunomid (HMR1726)|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00622700

Studie 20:
Titel: Randomisierte Bewertung der Langzeit-Antikoagulanzientherapie (VERLASSEN) Mit Dabigatranetexilat
Recruitment: Completed
Study Results: Has Results
Conditions: Vorhofflimmern|Schlaganfall
Interventions: Arzneimittel: Warfarin|Arzneimittel: Dabigatran-Dosis 1|Arzneimittel: Dabigatran-Dosis 2
URL: http://ClinicalTrials.gov/show/NCT00262600

Studie 21:
Titel: 24-einwöchige Studie zum Vergleich von GSK573719/GW642444 mit GW642444 und mit Tiotropium bei chronisch obstruktiver Lungenerkrankung
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Lungenerkrankung, Chronisch obstruktiv|Chronische Bronchitis|Emphysem
Interventions: Arzneimittel: GSK573719/GW642444 125/25|Arzneimittel: GSK573719/GW642444 62.5/25|Arzneimittel: GW642444|Arzneimittel: Tiotropiumbromid
URL: http://ClinicalTrials.gov/show/NCT01316900

Studie 22:
Titel: Wirksamkeits- und Sicherheitsstudie von Apixaban zur Behandlung von tiefer Venenthrombose oder Lungenembolie
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Venöse Thrombose
Interventions: Arzneimittel: Enoxaparin|Arzneimittel: Warfarin|Arzneimittel: Placebo für Apixaban|Arzneimittel: Placebo für Enoxaparin|Arzneimittel: Placebo für Warfarin|Arzneimittel: Apixaban
URL: http://ClinicalTrials.gov/show/NCT00643201

Studie 23:
Titel: Logik – Lapatinib-Optimierungsstudie in ErbB2 (HER2) Positiver Magenkrebs: Ein Phase-III-Global, Verblindete Studie zur Bewertung klinischer Endpunkte und Sicherheit der Chemotherapie plus Lapatinib
Recruitment: Recruiting
Study Results: No Results Available
Conditions: oder Adenokarzinom des gastroösophagealen Übergangs, das aufgrund einer lokal fortgeschrittenen Metastasierung nicht resezierbar ist, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Neoplasms, Gastrointestinal Tract|Speiseröhre
Interventions: Arzneimittel: Lapatinib|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00680901

Studie 24:
Titel: A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Major Depressive Disorder
Interventions: Arzneimittel: LY2216684|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01173601

Studie 25:
Titel: Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Recruitment: Completed
Study Results: Has Results
Conditions: Arthrose|Arthritis, Rheumatoid
Interventions: Arzneimittel: Celecoxib|Arzneimittel: Diclofenac + Omeprazole
URL: http://ClinicalTrials.gov/show/NCT00141102

Studie 26:
Titel: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Recruitment: Completed
Study Results: No Results Available
Conditions: Venöse Thrombose|Pulmonary Embolism
Interventions: Arzneimittel: Apixaban|Arzneimittel: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00457002

Studie 27:
Titel: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Rheumatoide Arthritis|Psoriasis-Arthritis|Spondylitis ankylosans
Interventions:
URL: http://ClinicalTrials.gov/show/NCT01078402

Studie 28:
Titel: The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: CV Risk|Arteriosklerose|Herz-Kreislauf-Erkrankungen|Coronary Heart Disease
Interventions: Arzneimittel: Darapladib|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00799903

Studie 29:
Titel: Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Recruitment: Completed
Study Results: Has Results
Conditions: Bacterial Pneumonia
Interventions: Arzneimittel: Ceftaroline fosamil for Injection|Arzneimittel: IV Ceftriaxone|Arzneimittel: Placebo|Arzneimittel: Clarithromycin
URL: http://ClinicalTrials.gov/show/NCT00621504

Studie 30:
Titel: A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Recruitment: Completed
Study Results: No Results Available
Conditions: Diabetes mellitus, Typ 2
Interventions: Arzneimittel: aleglitazar|Arzneimittel: Actos
URL: http://ClinicalTrials.gov/show/NCT00461006

Studie 31:
Titel: Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Conditions: Schizophrenie
Interventions: Arzneimittel: Placebo|Arzneimittel: RGH-188|Arzneimittel: RGH-188|Arzneimittel: RGH-188|Arzneimittel: Risperidon
URL: http://ClinicalTrials.gov/show/NCT00694707

Studie 32:
Titel: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Diabetes mellitus, Typ 2|Acute Coronary Syndrome
Interventions: Arzneimittel: Alogliptin|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00968708

Studie 33:
Titel: Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Metastasierter Darmkrebs
Interventions: Arzneimittel: Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)|Arzneimittel: Matching placebo + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
URL: http://ClinicalTrials.gov/show/NCT00865709

Studie 34:
Titel: Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Recruitment: Completed
Study Results: No Results Available
Conditions: Refractory Partial Seizures
Interventions: Arzneimittel: perampanel|Arzneimittel: perampanel|Arzneimittel: perampanel|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00700310

Studie 35:
Titel: BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Multiple Sklerose
Interventions: Arzneimittel: laquinimod|Arzneimittel: Placebo|Arzneimittel: Interferon β-1a (Avonex®)
URL: http://ClinicalTrials.gov/show/NCT00605215

Studie 36:
Titel: Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Arthritis, Rheumatoid|Arthrose
Interventions: Arzneimittel: celecoxib|Arzneimittel: Ibuprofen|Arzneimittel: Naproxen
URL: http://ClinicalTrials.gov/show/NCT00346216

Studie 37:
Titel: Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Recruitment: Beendet
Study Results: No Results Available
Conditions: Vorhofflimmern
Interventions: Arzneimittel: SSR126517E “biotinylated idraparinux”|Arzneimittel: Warfarin
URL: http://ClinicalTrials.gov/show/NCT00580216

Studie 38:
Titel: A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Arzneimittel: SKP FlutiForm HFA pMDI
URL: http://ClinicalTrials.gov/show/NCT00747318

Studie 39:
Titel: A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Recruitment: Enrolling by invitation
Study Results: No Results Available
Conditions: Relapsing Multiple Sclerosis
Interventions: Arzneimittel: Laquinimod
URL: http://ClinicalTrials.gov/show/NCT01047319

Studie 40:
Titel: Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Multiple Sklerose, Relapsing-remitting
Interventions: Arzneimittel: daclizumab HYP|Andere: Placebo
URL: http://ClinicalTrials.gov/show/NCT00390221

Studie 41:
Titel: A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injektion 40 mg Administered Three Times a Week Compared to Placebo
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: Arzneimittel: Glatiramer acetate (GA)|Andere: Placebo
URL: http://ClinicalTrials.gov/show/NCT01067521

Studie 42:
Titel: TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Recruitment: Completed
Study Results: No Results Available
Conditions: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Arzneimittel: TR-701 FA|Arzneimittel: Linezolid
URL: http://ClinicalTrials.gov/show/NCT01170221

Studie 43:
Titel: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Recruitment: Completed
Study Results: No Results Available
Conditions: Vorhofflimmern|Atrial Flutter
Interventions: Arzneimittel: Tedisamil sesquifumarate
URL: http://ClinicalTrials.gov/show/NCT00126022

Studie 44:
Titel: Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma bronchiale
Interventions: Arzneimittel: Beclomethasone dipropionate|Arzneimittel: Beclomethasone dipropionate/Salbutamol combination|Arzneimittel: Salbutamol
URL: http://ClinicalTrials.gov/show/NCT00497523

Studie 45:
Titel: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Tumor Antigen-positive Non-Small Cell Lung Cancer|Lung Cancer, Non-Small Cell
Interventions: Biologisch: GSK1572932A Antigen-Specific Cancer Immunotherapeutic|Biologisch: Placebo Control
URL: http://ClinicalTrials.gov/show/NCT00480025

Studie 46:
Titel: A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Arzneimittel: FlutiForm 250/10|Arzneimittel: SKP-Fluticasone|Arzneimittel: Flovent Fluticasone HFA
URL: http://ClinicalTrials.gov/show/NCT00649025

Studie 47:
Titel: FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Recruitment: Completed
Study Results: No Results Available
Conditions: Acute Coronary Syndrome
Interventions: Arzneimittel: Varespladib Methyl (A-002)
URL: http://ClinicalTrials.gov/show/NCT00743925

Studie 48:
Titel: A Double-blind, Placebo-controlled, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer’s Disease.
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Alzheimer Disease|Dementia, Alzheimer Type
Interventions: Arzneimittel: Galantamine|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00679627

Studie 49:
Titel: The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Arteriosklerose|Acute Coronary Syndrome|Herz-Kreislauf-Erkrankungen|Coronary Heart Disease
Interventions: Arzneimittel: Darapladib 160 mg|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01000727

Studie 50:
Titel: Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Adolescent Schizophrenia|Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Interventions: Arzneimittel: Aripiprazole
URL: http://ClinicalTrials.gov/show/NCT01122927

Studie 51:
Titel: PALMFlexS: Paliperidone Palmitate Flexible Dosing in Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizophrenie
Interventions: Arzneimittel: Paliperidone Palmitate
URL: http://ClinicalTrials.gov/show/NCT01281527

Studie 52:
Titel: MICHELANGELO OASIS-6 : Fondaparinux in ST Elevation Myocardial Infarction
Recruitment: Completed
Study Results: No Results Available
Conditions: Myokardinfarkt|ST-elevation Myocardial Infarction|Acute Coronary Syndrome|Acute Myocardial Infarction
Interventions: Arzneimittel: Fondaparinux – UFH indicated|Andere: Control – UFH not indicated|Arzneimittel: fondaparinux – UFH not indicated|Arzneimittel: Control – UFH
URL: http://ClinicalTrials.gov/show/NCT00064428

Studie 53:
Titel: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
Recruitment: Completed
Study Results: No Results Available
Conditions: Dyslipidemia/Glucose Metabolism Disorder
Interventions: Arzneimittel: fenofibrate and metformin combination (Arzneimittel)
URL: http://ClinicalTrials.gov/show/NCT00349128

Studie 54:
Titel: A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Conditions: Vorhofflimmern
Interventions: Arzneimittel: YM150|Arzneimittel: Warfarin
URL: http://ClinicalTrials.gov/show/NCT00938730

Studie 55:
Titel: Study of Paclitaxel in Patients With Ovarian Cancer
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
Interventions: Arzneimittel: Paclical®|Arzneimittel: Taxol®
URL: http://ClinicalTrials.gov/show/NCT00989131

Studie 56:
Titel: Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Recruitment: Completed
Study Results: No Results Available
Conditions: Hyperlipidemia
Interventions: Arzneimittel: fenofibrate / simvastatin|Arzneimittel: Atorvastatin
URL: http://ClinicalTrials.gov/show/NCT00362934

Studie 57:
Titel: Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Recruitment: Completed
Study Results: No Results Available
Conditions: Vorhofflimmern
Interventions: Arzneimittel: Placebo|Arzneimittel: Vernakalant (oral)
URL: http://ClinicalTrials.gov/show/NCT00526136

Studie 58:
Titel: Safety of Inhaled Insulin With Type 1 und Typ 2 Diabetes
Recruitment: Completed
Study Results: No Results Available
Conditions: Diabetes, Type I|Diabetes Type 2
Interventions: Arzneimittel: Technosphere Insulin|Arzneimittel: Usual Care|Andere: No Intervention
URL: http://ClinicalTrials.gov/show/NCT00308737

Studie 59:
Titel: Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Arzneimittel: Beclomethasone plus formoterol fixed combination|Arzneimittel: Fluticasone plus salmeterol fixed combination
URL: http://ClinicalTrials.gov/show/NCT00497237

Studie 60:
Titel: Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Lungenerkrankung, Chronisch obstruktiv
Interventions: Arzneimittel: tiotropium 2.5 mcg|Arzneimittel: tiotropium 5 mcg|Arzneimittel: Tiotropium 18 mcg
URL: http://ClinicalTrials.gov/show/NCT01126437

Studie 61:
Titel: Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Essential Hypertension
Interventions: Arzneimittel: Olmesartan medoxomil 40 mg – Amlodipine 10 mg|Arzneimittel: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg|Arzneimittel: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg|Arzneimittel: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg|Arzneimittel: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg|Arzneimittel: OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg
URL: http://ClinicalTrials.gov/show/NCT00902538

Studie 62:
Titel: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes mellitus
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Typ 2 Diabetes mellitus
Interventions: Arzneimittel: Exenatide Once Weekly|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01144338

Studie 63:
Titel: Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Arzneimittel: Fluticasone furoate/Vilanterol Inhalation Powder|Arzneimittel: Fluticasone Furoate Inhalation Powder|Arzneimittel: Placebo Inhaltion Powder
URL: http://ClinicalTrials.gov/show/NCT01165138

Studie 64:
Titel: Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Recruitment: Completed
Study Results: Has Results
Conditions: Diabetes mellitus, Typ 2
Interventions: Arzneimittel: linagliptin|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00621140

Studie 65:
Titel: Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Multiple Sklerose, Relapsing-Remitting
Interventions: Arzneimittel: Daclizumab HYP|Arzneimittel: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT00870740

Studie 66:
Titel: Phase III Acute Coronary Syndrome
Recruitment: Beendet
Study Results: No Results Available
Conditions: Acute Coronary Syndrome
Interventions: Arzneimittel: Apixaban|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00831441

Studie 67:
Titel: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Recruitment: Beendet
Study Results: No Results Available
Conditions: Breast Neoplasms|Neoplasms, Hormone-Dependent
Interventions: Arzneimittel: Atamestane|Arzneimittel: Toremifene|Arzneimittel: Letrozole|Arzneimittel: Aromatase inhibition|Arzneimittel: Estrogen receptor blocker|Verfahren: Hormone therapy|Verfahren: Endocrine therapy|Verfahren: Antiestrogen therapy
URL: http://ClinicalTrials.gov/show/NCT00097344

Studie 68:
Titel: Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
Recruitment: Completed
Study Results: No Results Available
Conditions: Asthma
Interventions: Arzneimittel: Fluticasone Propionate 100mcg BD|Arzneimittel: GSK2190915 100mg|Arzneimittel: GSK2190915 10mg|Arzneimittel: GSK2190915 300mg|Arzneimittel: GSK2190915 30mg|Arzneimittel: Montelukast 10mg|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01147744

Studie 69:
Titel: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma
Recruitment: Completed
Study Results: Has Results
Conditions: Non-Hodgkin’s Lymphoma
Interventions: Arzneimittel: Bortezomib + Rituximab|Arzneimittel: Rituximab
URL: http://ClinicalTrials.gov/show/NCT00312845

Studie 70:
Titel: TroVax Renal Immunotherapy Survival Trial
Recruitment: Completed
Study Results: No Results Available
Conditions: Clear Cell Renal Carcinoma
Interventions: Biologisch: Trovax
URL: http://ClinicalTrials.gov/show/NCT00397345

Studie 71:
Titel: PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
Recruitment: Completed
Study Results: No Results Available
Conditions: Coronary Artery Disease (CAD)
Interventions: Arzneimittel: A-002
URL: http://ClinicalTrials.gov/show/NCT00455546

Studie 72:
Titel: VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Acute Coronary Syndrome
Interventions: Arzneimittel: A-002, varespladib methyl|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01130246

Studie 73:
Titel: Eslicarbazepine Acetate Monotherapy Long Term Study
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Epilepsie
Interventions: Arzneimittel: Eslicarbazepine acetate
URL: http://ClinicalTrials.gov/show/NCT00910247

Studie 74:
Titel: Effectiveness and Safety of Flexible Doses of Paliperidone Prolonged Release in Adolescent Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizophrenie
Interventions: Arzneimittel: Aripiprazole|Arzneimittel: Paliperidone PR
URL: http://ClinicalTrials.gov/show/NCT01009047

Studie 75:
Titel: Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
Recruitment: Completed
Study Results: No Results Available
Conditions: Venous Thromboembolism
Interventions: Arzneimittel: Xarelto (Rivaroxaban, BAY59-7939)|Arzneimittel: Enoxaparin
URL: http://ClinicalTrials.gov/show/NCT00571649

Studie 76:
Titel: Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Metastatic Pancreatic Cancer
Interventions: Arzneimittel: Albumin-bound paclitaxel (ABI-007)/Gemcitabine|Arzneimittel: Gemcitabine
URL: http://ClinicalTrials.gov/show/NCT00844649

Studie 77:
Titel: Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing Remitting Multiple Sclerosis
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Multiple Sklerose, Relapsing-Remitting
Interventions: Arzneimittel: Daclizumab HYP
URL: http://ClinicalTrials.gov/show/NCT01051349

Studie 78:
Titel: GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis
Recruitment: Completed
Study Results: No Results Available
Conditions: Rheumatoide Arthritis
Interventions: Arzneimittel: GLPG0259 oral capsule|Arzneimittel: Placebo|Arzneimittel: GLPG0259 (Part B)|Arzneimittel: Placebo (Part B)
URL: http://ClinicalTrials.gov/show/NCT01211249

Studie 79:
Titel: A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Cancer After Chemotherapy
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Non-Small Cell Lung Cancer
Interventions: Arzneimittel: erlotinib [Tarceva]|Arzneimittel: Placebo|Arzneimittel: erlotinib [Tarceva]
URL: http://ClinicalTrials.gov/show/NCT01328951

Studie 80:
Titel: Comparison of Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Typ 1 Diabetes mellitus
Interventions: Arzneimittel: Technosphere® Insulin with Gen2 Inhaler|Arzneimittel: Insulin aspart, basal insulin|Arzneimittel: Technosphere® Insulin with MedTone C Inhaler
URL: http://ClinicalTrials.gov/show/NCT01445951

Studie 81:
Titel: Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Peripheral Arterial Occlusive Disease
Interventions: Arzneimittel: Alprostadil|Andere: Placebo
URL: http://ClinicalTrials.gov/show/NCT00596752

Studie 82:
Titel: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Hypertonie
Interventions: Arzneimittel: fixed-dose combination of telmisartan 40mg+amlodipine 10mg|Arzneimittel: fixed-dose combination of telmisartan 80mg+amlodipine10mg
URL: http://ClinicalTrials.gov/show/NCT00624052

Studie 83:
Titel: The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia
Recruitment: Completed
Study Results: No Results Available
Conditions: Schizophrenie
Interventions: Arzneimittel: Cariprazine
URL: http://ClinicalTrials.gov/show/NCT00839852

Studie 84:
Titel: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
Recruitment: Completed
Study Results: Has Results
Conditions: Thrombosis, Venous|Superficial Thrombophlebitis
Interventions: Arzneimittel: Fondaparinux 2.5mg or placebo
URL: http://ClinicalTrials.gov/show/NCT00443053

Studie 85:
Titel: A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizoaffective Disorder
Interventions: Arzneimittel: Placebo|Arzneimittel: paliperidone palmitate
URL: http://ClinicalTrials.gov/show/NCT01193153

Studie 86:
Titel: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
Recruitment: Completed
Study Results: No Results Available
Conditions: Vorhofflimmern|Thromboembolism
Interventions: Arzneimittel: Edoxaban (DU-176b)|Arzneimittel: Edoxaban (DU-176b)|Arzneimittel: Edoxaban (DU-176b)|Arzneimittel: Edoxaban (DU-176b)|Arzneimittel: Warfarin
URL: http://ClinicalTrials.gov/show/NCT00504556

Studie 87:
Titel: Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Recruitment: Completed
Study Results: No Results Available
Conditions: Acne Vulgaris
Interventions: Arzneimittel: Valette|Arzneimittel: Diane|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT00280657

Studie 88:
Titel: Lurasidone – A 24-week Extension Study of Patients With Bipolar I Depression
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Bipolar|Depression
Interventions: Arzneimittel: lurasidone
URL: http://ClinicalTrials.gov/show/NCT00868959

Studie 89:
Titel: PRoFESS – Prevention Regimen For Effectively Avoiding Second Strokes
Recruitment: Completed
Study Results: Has Results
Conditions: Cerebrovascular Accident
Interventions: Arzneimittel: extended-release dipyridamole + aspirin|Arzneimittel: Clopidogrel|Arzneimittel: telmisartan
URL: http://ClinicalTrials.gov/show/NCT00153062

Studie 90:
Titel: Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Hypertonie
Interventions: Arzneimittel: amlodipine|Arzneimittel: telmisartan|Arzneimittel: telmisartan and amlodipine
URL: http://ClinicalTrials.gov/show/NCT00860262

Studie 91:
Titel: Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Epilepsie
Interventions: Arzneimittel: Eslicarbazepine acetate 1600 mg|Arzneimittel: Eslicarbazepine acetate 1200 mg
URL: http://ClinicalTrials.gov/show/NCT01091662

Studie 92:
Titel: Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Myokardinfarkt|Cardiovascular Death|Atherothrombosis|Schlaganfall
Interventions: Arzneimittel: Ticagrelor 90 mg|Arzneimittel: Ticagrelor 60 mg|Arzneimittel: Ticagrelor Placebo
URL: http://ClinicalTrials.gov/show/NCT01225562

Studie 93:
Titel: Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Multiple Myeloma
Interventions: Arzneimittel: Thalidomide and Dexamethasone|Arzneimittel: Dexamethasone
URL: http://ClinicalTrials.gov/show/NCT00057564

Studie 94:
Titel: Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Leukaemia, Lymphocytic, Chronic|Chronic Lymphocytic Leukemia
Interventions: Arzneimittel: OFC Infusion|Arzneimittel: FC infusion
URL: http://ClinicalTrials.gov/show/NCT00824265

Studie 95:
Titel: A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Recruitment: Completed
Study Results: No Results Available
Conditions: Mukoviszidose
Interventions: Arzneimittel: tobramycin|Arzneimittel: tobramycin
URL: http://ClinicalTrials.gov/show/NCT00885365

Studie 96:
Titel: Safety and Efficacy of Cariprazine in Patients With Schizophrenia
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Schizophrenie
Interventions: Arzneimittel: Cariprazine|Arzneimittel: Cariprazine|Arzneimittel: Aripiprazole|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01104766

Studie 97:
Titel: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Recruitment: Completed
Study Results: Has Results
Conditions: Hypertonie
Interventions: Arzneimittel: fixed dose combination of telmisartan+amlodipine|Arzneimittel: amlodipine
URL: http://ClinicalTrials.gov/show/NCT00553267

Studie 98:
Titel: Fenofibrate and Metformin Fixed Combination vs Rosiglitazone – FAME ROSI
Recruitment: Beendet
Study Results: No Results Available
Conditions: Dyslipidemia|Glucose Metabolism Disorder
Interventions: Arzneimittel: fenofibrate (F) + metformin (M) hydrochloride fixed combination|Arzneimittel: Rosiglitazone
URL: http://ClinicalTrials.gov/show/NCT00361868

Studie 99:
Titel: Safety and Efficacy of Cariprazine for Bipolar I Disorder
Recruitment: Recruiting
Study Results: No Results Available
Conditions: Mania|Bipolar I Disorder
Interventions: Arzneimittel: Cariprazine low dose|Arzneimittel: Cariprazine high dose|Arzneimittel: Placebo
URL: http://ClinicalTrials.gov/show/NCT01058668

Studie 100:
Titel: A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Recruitment: Active, not recruiting
Study Results: No Results Available
Conditions: Vorhofflimmern
Interventions: Arzneimittel: Apixaban|Arzneimittel: Acetylsalicylic Acid (ASA)|Arzneimittel: Apixaban
URL: http://ClinicalTrials.gov/show/NCT00496769